May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
May 31, 2017 13:33 pm UTC| Business
ORLANDO, Fla., May 31, 2017 -- Immune Therapeutics, Inc. (OTCQB:IMUN), a specialty pharmaceutical company focused on developing and commercializing our novel patented, affordable, non-toxic therapy for the management of...
Mike Rees Appointed as Chairman of Chirp to support the business during accelerated growth
May 31, 2017 13:32 pm UTC| Business
LONDON, May 31, 2017 -- Chirp, the global leader in data-over-sound technology solutions, today announced that the Company’s board of directors has appointed Mike Rees, the former deputy CEO of Standard Chartered PLC,...
US–India Trade Turbocharge: Stocks Poised to Ride the Export Wave